CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-21 | SANDELL SCOTT D 10% owner | Purchase | +104,844 | $1.81 | $190K | 72,243,844 |
| 2018-03-21 | MOTT DAVID M Director | Purchase | +104,844 | $1.81 | $190K | 72,243,844 |
| 2018-03-21 | KERINS PATRICK J 10% owner | Purchase | +104,844 | $1.81 | $190K | 72,243,844 |
| 2018-03-21 | Florence Anthony A. Jr. 10% owner | Purchase | +104,844 | $1.81 | $190K | 72,243,844 |
| 2018-03-21 | BASKETT FOREST 10% owner | Purchase | +104,844 | $1.81 | $190K | 72,243,844 |
| 2018-03-21 | BARRIS PETER J 10% owner | Purchase | +104,844 | $1.81 | $190K | 72,243,844 |
| 2018-03-21 | BARRETT M JAMES 10% owner | Purchase | +104,844 | $1.81 | $190K | 72,243,844 |
| 2018-03-21 | New Enterprise Associates 14, L.P. 10% owner | Purchase | +104,844 | $1.81 | $190K | 72,243,844 |
| 2018-03-20 | Rawcliffe Adrian Chief Financial Officer | Sale | −600,000 | $1.71 | $1.0M | 0 |
| 2018-01-12 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Grant or award · Option to purchase Ordinary Shares | +687,984 | 687,984 | ||
| 2018-01-12 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Grant or award · Option to purchase Ordinary Shares | +153,648 | 153,648 | ||
| 2018-01-12 | Rawcliffe Adrian Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +687,984 | 687,984 | ||
| 2018-01-12 | Rawcliffe Adrian Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +153,648 | 153,648 | ||
| 2018-01-12 | Binder-Scholl Gwendolyn Knowlton Chief Technology Officer | Grant or award · Option to purchase Ordinary Shares | +429,984 | 429,984 | ||
| 2018-01-12 | Binder-Scholl Gwendolyn Knowlton Chief Technology Officer | Grant or award · Option to purchase Ordinary Shares | +96,036 | 96,036 | ||
| 2018-01-12 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +644,976 | 644,976 | ||
| 2018-01-12 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +144,048 | 144,048 | ||
| 2018-01-12 | Amado Rafael Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +859,968 | 859,968 | ||
| 2018-01-12 | Amado Rafael Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +192,060 | 192,060 | ||
| 2018-01-12 | Noble James Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +1,719,936 | 1,719,936 |
Page 21 of 24 · 470 trades